Leukemia
Allogeneic transplant may be considered for selected acute or chronic leukemias based on risk and treatment response.
Hematopoietic stem cell transplantation
Bone Marrow Transplant in Turkey
Information about bone marrow and blood stem cell transplant in Turkey, including indications, transplant types, donor matching, treatment stages, medical records, risks, and cost factors.
Specialized transplant assessmentThe transplant type and timing are determined for the individual diagnosis.
Donor and HLA evaluationMatching and donor suitability are central to allogeneic transplantation.
Infection and complication monitoringClose follow-up is required before, during, and after transplant.
What to know
Bone marrow transplant is more accurately called hematopoietic stem cell transplant
Blood-forming stem cells can be collected from peripheral blood, bone marrow, or cord blood. The procedure is used to restore blood-cell production after intensive treatment and, in selected donor transplants, may also provide an immune effect against the disease.
Transplantation is not appropriate for every patient with leukemia, lymphoma, myeloma, or marrow failure. The transplant team weighs disease risk, response to prior treatment, age, organ function, infections, donor options, and the risks of the procedure.
Conditions and clinical areas
Conditions for which transplantation may be considered
The indication and preferred transplant type vary by diagnosis, disease status, previous treatment, and patient-specific factors.
Lymphoma
Autologous or allogeneic transplant may be used in selected relapsed or high-risk lymphomas.
Multiple myeloma
Autologous stem cell transplant is part of treatment for some medically suitable patients.
Myelodysplastic and marrow disorders
Allogeneic transplantation may be considered for selected myelodysplastic syndromes, myelofibrosis, or marrow-failure conditions.
Aplastic anemia and immune disorders
Donor transplantation may be an option for selected severe marrow-failure or immune-system diseases.
Inherited blood diseases
Certain hemoglobin, metabolic, or immune disorders may be evaluated for transplantation by specialized teams.
Diagnosis and evaluation
Assessment before a stem cell transplant
Pre-transplant testing evaluates the disease, treatment response, organ function, infection risk, and donor options.
Disease and marrow evaluation
Pathology, bone marrow tests, flow cytometry, genetics, and measurable disease assessment may be reviewed.
Organ and infection screening
Heart, lung, liver, kidney, dental, and infectious-disease assessments are commonly required.
HLA typing and donor search
For allogeneic transplant, the team assesses related, unrelated, haploidentical, or cord-blood donor options.
Possible treatment approaches
The transplant pathway includes several distinct stages
The exact sequence differs between autologous and allogeneic transplantation and according to the underlying disease.
Stem cell collection
Cells are collected from the patient or donor, most often from peripheral blood after mobilization.
Conditioning treatment
Chemotherapy, and sometimes radiation, prepares the body and treats the underlying disease before infusion.
Stem cell infusion
The collected cells are given through a vein, similar to a blood transfusion.
Engraftment monitoring
Blood counts, infections, bleeding, and organ function are monitored while new cells begin producing blood.
GVHD prevention and treatment
After donor transplant, medicines and monitoring are used to reduce graft-versus-host disease risk.
Long-term follow-up
Vaccination, immune recovery, disease monitoring, fertility, and late effects require continued specialist care.
Medical records
Records needed for a transplant opinion
A transplant team needs detailed information about both the disease and the patient’s overall health.
Medical history and treatment summaryDiagnosis, disease course, chemotherapy or immunotherapy, response, complications, and current condition.
Pathology and bone marrow resultsBiopsy reports, flow cytometry, cytogenetics, molecular findings, and measurable residual disease results.
Imaging and response assessmentPET-CT, CT, MRI, or other studies showing current disease status when relevant.
Recent laboratory testsBlood counts, kidney and liver function, infection screening, and other baseline tests.
Organ-function reportsCardiology, pulmonary testing, and other evaluations already completed.
HLA and donor informationExisting HLA typing, family donor testing, registry-search information, or previous donor assessments.
Specialist departments
Teams involved in stem cell transplantation
Transplant care requires coordinated work across hematology, laboratory medicine, infectious diseases, intensive care, and supportive specialties.
Transplant hematology
Determines indication, transplant type, conditioning, and post-transplant strategy.
HLA and stem cell laboratory
Performs tissue typing, compatibility testing, cell processing, and quality control.
Infectious diseases
Guides infection screening, prevention, and treatment during immune suppression.
Transfusion medicine
Provides blood products and supports stem cell collection and processing.
Critical and supportive care
Intensive care, nephrology, cardiology, nutrition, and pain teams may be needed.
Long-term survivorship care
Monitors immune recovery, vaccination, endocrine health, fertility, and late complications.
Treatment cost in Turkey
Transplant cost depends on the type and clinical complexity
A reliable estimate requires medical review. Autologous and allogeneic transplantation have different resource needs, and donor search, complications, hospital stay, and medicines can significantly affect cost. More general information is available on the treatment pricing page.
- Autologous, matched donor, unrelated donor, or haploidentical transplant
- Disease evaluation, HLA typing, and donor testing
- Conditioning regimen and stem cell collection
- Length of hospitalization and isolation
- Complications, medicines, transfusions, and follow-up
Frequently asked questions
Answers before sending medical records
What is the difference between autologous and allogeneic transplant?
Autologous transplant uses the patient’s own previously collected cells. Allogeneic transplant uses cells from a donor and introduces both donor immune effects and additional risks such as graft-versus-host disease.
Is bone marrow always the source of stem cells?
No. Most transplants use blood-forming stem cells collected from peripheral blood, although bone marrow or cord blood may also be used.
How is a donor selected?
The transplant team uses HLA tissue typing and assesses donor health, availability, relationship, and other clinical factors.
How long is hospitalization?
It varies with transplant type, conditioning, engraftment, infections, complications, and the hospital protocol. The transplant center provides an individualized estimate.
Can a transplant opinion be obtained remotely?
Often, the first specialist review can be based on the medical summary, pathology, marrow results, genetics, imaging, and treatment history.
What are important risks?
Risks include infection, bleeding, organ toxicity, delayed engraftment, relapse, and—after donor transplant—graft-versus-host disease. The team explains risks for the specific case.
Can the cost be calculated before travel?
A preliminary estimate may be possible after detailed review, but complications or changes in the clinical plan can affect the final cost.
When should urgent local care be sought?
Fever during immune suppression, severe bleeding, breathing difficulty, confusion, or sudden deterioration requires immediate local medical care.
Contact Medicina Turkey
Do you need a bone marrow transplant opinion in Turkey?
Send the diagnosis, treatment history, latest disease assessment, bone marrow and genetic results, organ-function reports, and any available HLA or donor information.
Medical sources:
- National Cancer Institute — Stem Cell Transplants
- NCI Dictionary — Autologous Stem Cell Transplant
- NCI Dictionary — Allogeneic Stem Cell Transplant
- National Cancer Institute — Donating Blood Stem Cells
This page provides general educational information and does not replace a medical examination, diagnosis, or individualized treatment plan. Treatment options and outcomes vary according to the clinical situation.